Article
Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis.
Human molecular genetics - 15 Nov 2008
Maxwell James R, Potter Catherine, Hyrich Kimme L, Barton Anne, Worthington Jane, Isaacs John D, Morgan Ann W, Wilson Anthony G
Abstract excerpt
Anti-tumour necrosis factor (TNF) agents have revolutionized the treatment of patients with rheumatoid arthritis (RA). These therapies are, however, expensive and 30% of patients fail to respond. In a large cohort of Caucasian RA patients treated with anti-TNF medications (total n = 1050, etanercept n = 455, infliximab n = 450), we investigated whether genotypes of eight single nucleotide polymorphisms in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
